Parathyroid hormone-related protein in preeclampsia: A linkage between maternal and fetal failures

Biology of Reproduction

Volumn 71, Issue 6, 2004, Pages 1779-1784

  Maioli, Emanuela ^a,b   Fortino, Vittoria ^a   Pacini, Adriana ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Department of Physiology ^*  (Italy)

Author keywords

Apoptosis; Cytokines; Placenta; Pregnancy; Trophoblast

Indexed keywords

CYTOKINE; PARATHYROID HORMONE RELATED PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; CELL INVASION; EDEMA; FEMALE; FETOPLACENTAL UNIT; FETUS; FETUS DEVELOPMENT; FETUS GROWTH; GENETIC LINKAGE; GROWTH RETARDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; MATERNAL CARE; MATERNAL HYPERTENSION; MOUSE; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEINURIA; REPRODUCTION; SHORT SURVEY; TROPHOBLAST;

CYTOKINES; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; HUMANS; PARATHYROID HORMONE-RELATED PROTEIN; PRE-ECLAMPSIA; PREGNANCY;

ANIMALIA;

EID: 9744278277     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.104.030932     Document Type: Short Survey

References (69)

1. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987; 237:893-896.
2. Maioli E, Fortino V. The complexity of parathyroid hormone-related peptide (PTHrP) signaling. Cell Mol Life Sci 2004; 61:257-262.
3. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 1996; 76:127-173.
4. Farrugia W, Ho PW, Rice GE, Moseley JM, Permezel M, Wlodek ME. Parathyroid hormone-related protein (1-34) in gestational fluids and release from human gestational tissues. J Endocrinol 2000; 165: 657-662.
5. Thiede MA, Daifotis AG, Weir EC, Brines ML, Burtis WJ, Ikeda K, Dreyer BE, Garfield RE, Broadus AE. Intrauterine occupancy controls expression of the parathyroid hormone-related peptide gene in preterm rat myometrium. Proc Natl Acad Sci U S A 1990; 87:6969-6973.
6. Pitera AE, Smith GC, Wentworth RA, Nathanieisz PW. Parathyroid hormone-related peptide (1 to 34) inhibits in vitro oxytocin-stimulated activity of pregnant baboon myometrium. Am J Obstet Gynecol 1998; 179:492-496.
7. Wu WX, Bruns ME, Bruns D, Seaner R, Nathanielsz PW, Ferguson JE II. Parathyroid hormone-related protein mRNA in sheep endometrium and myometrium during late gestation and labor. J Soc Gynecol Investig 1998; 5:127-131.
8. Ferguson JE II, Gorman JV, Bruns DE, Weir EC, Burtis WJ, Martin TJ, Bruns ME. Abundant expression of parathyroid hormone-related protein in human amnion and its association with labor. Proc Natl Acad Sci U S A 1992; 89:8384-8388.
9. Curtis NE, King RG, Moseley JM, Ho PW, Rice GE, Wlodek ME. Intrauterine expression of parathyroid hormone-related protein in normal and preeclamptic pregnancies. Placenta 1998; 19:595-601.
10. Farrugia W, de Gooyer T, Rice GE, Moseley JM, Wlodek ME. Parathyroid hormone (1-34) and parathyroid hormone-related protein (1-34) stimulate calcium release from human syncytiotrophoblast basal membranes via a common receptor. J Endocrinol 2000; 166:689-695.
11. Strid H, Care A, Jansson T, Powell T. Parathyroid hormone-related peptide (38-94) amide stimulates ATP-dependent calcium transport in the Basal plasma membrane of the human syncytiotrophoblast. J Endocrinol 2002; 175:517-524.
12. Mandsager NT, Brewer AS, Myatt L. Vasodilatator effects of parathyroid hormone, parathyroid hormone-related protein and calcitonin gene-related peptide in the human fetal-placental circulation. J Soc Gynecol Investig 1994; 1:19-24.
13. Wysolmerski JJ, Stewart AF. The physiology of parathyroid hormone-related protein: an emerging role as developmental factor. Annu Rev Physiol 1998; 60:431-460.
14. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994; 8:277-289.
15. Qian J, Colbert MC, Witte D, Kuan CY, Gruenstein E, Osinska H, Lanske B, Kronenberg HM, Clemens TL. Midgestational lethality in mice lacking the parathyroid hormone (PTH)/PTH-related peptide receptor is associated with abrupt cardiomyocyte death. Endocrinology 2003; 144:1053-1061.
16. Karaplis AC, He B, Nguyen MT, Young ID, Semeraro D, Ozawa H, Amizuka N. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology 1998; 139:5255-5258.
17. Curtis NE, Ho PW, King RG, Farrugia W, Moses EK, Gillespie MT, Moseley JM, Rice GE, Wlodek ME. The expression of parathyroid hormone-related protein mRNA and immunoreactive protein in human amnion and choriodecidua is increased at term compared with preterm gestation. J Endocrinol 1997; 154:103-112.
18. Wlodek ME, Di Nicolantonio R, Westcott KT, Farrugia W, Ho PWM, Moseley JM. PTHrP receptor and mid-molecule PTHrP regulation of intrauterine PTHrP: PTHrP receptor antagonism increases SHR fetal weight. Placenta 2004; 1:53-61.
19. Wang R, Wu LY, Karpinski E, Pang PK. The effects of parathyroid hormone on L-type voltage-dependent calcium channel currents in vascular smooth muscle cells and ventricular myocytes are mediated by a cyclic AMP dependent mechanism. FEBS Lett 1991: 282:331-334.
20. Kara M, Liu YM, Zhen L, Cohen IS, Yu H, Danilo P Jr, Ogino K, Bilezikian JP, Rosen MR. Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential. Circulation 1997; 96:3704-3709.
21. Lorenzo O, Ruiz-Ortega M, Esbrit P, Ruperez M, Ortega A, Santos S, Blanco J, Ortega L, Egido J. Angiotensin II increases parathyroid hormone-related protein (PTHrP) and the type 1 PTH/PTHrP receptor in the kidney. J Am Soc Nephrol 2002; 13:1595-1607.
22. 1A- adrenoceptors and improves resistance against apoptosis in coronary endothelial cells. Mol Pharmacol 2003; 63:111-118.
23. Garcia SI, Clemens TL, Fagin JA, Finkielman S, Pirola CJ. Parathyroid hormone-related protein expression in vascular smooth muscle of spontaneously hypertensive rats: evidence for lack of response to angiotensin II. J Hypertens 1998; 16:1467-1474.
24. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 1997; 18:832-872.
25. Hirota Y, Anai T, Miyakawa I. Parathyroid hormone-related protein levels in maternal and cord blood. Am J Obstet Gynecol 1997; 177: 702-706.
26. Wlodek ME, Koutsis K, Westcott KT, Ho PW, Di Nicolantonio R, Moseley JM. The spontaneously hypertensive rat fetus, not the mother, is responsible for the reduced amniotic fluid PTHrP concentrations and growth restriction. Placenta 2001; 22:646-651.
27. Alexander BT, Bennett WA, Khalil RA, Granger JP. Preeclampsia: linking placental ischemia with cardiovascular-renal dysfunction. News Physiol Sci 2001; 16:282-286.
28. Roberts JM, Lain KY. Recent insights into the pathogenesis of preeclampsia. Placenta 2002; 23:359-372.
29. Halkali A, Wimalawansa SJ, Berentsen V, Avila E, Thota CS, Larrea F. Calcitonin gene- and parathyroid hormone-related peptides in preeclampsia: effects of magnesium sulfate. Obstet Gynecol 2001; 97: 893-397.
30. Nickols GA, Nana AD, Nickols MA, DiPette DJ, Asimakis GK. Hypotension and cardiac stimulation due to the parathyroid hormone-related protein, humoral hypercalcemia of malignancy factor. Endocrinology 1989; 125:834-841.
31. Kisters K, Barenbrock M, Louwen F, Hausberg M, Rahn KH, Kosch M. Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia. Am J Hypertens 2000; 13:765-769.
32. Hofmeyr GJ, Roodt A, Atallah AN, Duley L. Calcium supplementation to prevent preeclampsia - a systematic review. S Afr Med J 2003; 93:224-228.
33. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, DerSimonian R, Esterlitz JR, Raymond EG, Bild DE, Clemens JD, Cutler JA. Trial of calcium to prevent preeclampsia. N Engl J Med 1997; 337:69-76.
34. Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perinatal 2000; 24:24-28.
35. Ishikawa M, Akishita M, Kozaki K, Toba K, Namiki A, Yamaguchi T, Orimo H, Ouchi Y. Expression of parathyroid hormone-related protein in human and experimental atherosclerotic lesions: functional role in arterial intimal thickening. Atherosclerosis 2000; 152:97-105.
36. Caniggia I, Winter JL. Hypoxia inducibile factor-1: oxygen regulation of trophoblast differentiation in normal and preeclamptic pregnancies - a review. Placenta 2002; 16:S47-S57.
37. Redman CWG, Sargent IL. Placental debris, oxidative stress, and preeclampsia. Placenta 2000; 21:597-602.
38. Campbell S, Rowe J, Jackson CJ, Gallery ED. In vitro migration of cytotrophoblasts through a decidual endothelial cell monolayer: the role of matrix metalloproteinases. Placenta 2003; 24:306-315.
39. 2α reduces trophoblast invasion and matrix metalloproteinase activity. Hypertension 2000; 35:1307-1313.
40. Kawashima-Ohya Y, Satakeda H, Kuruta Y, Kawamoto T, Yan W, Akagawa Y, Hayakawa T, Noshiro M, Okada Y, Nakamura S, Kato Y. Effects of parathyroid hormone (PTH) and PTH-related peptide on expressions of matrix metalloproteinase-2, -3, and -9 in growth plate chondrocyte cultures. Endocrinology 1998; 139:2120-2127.
41. Uchida M, Yamato H, Nagai Y, Yamagiwa H, Hayami T, Tokunaga K, Endo N, Suzuki H, Obara K, Fujieda A, Murayama H, Fukumoto S. Parathyroid hormone increases the expression level of matrix metalloproteinase-13 in vivo. J Bone Miner Metab 2001; 19:207-212.
42. Maioli E, Fortino V, Torricelli C, Arezzini B, Gardi C. Effect of parathyroid hormone-related protein on fibroblast proliferation and collagen metabolism in human skin. Exp Dermatol 2002; 11:302-310.
43. Levy R, Smith SD, Chandler K, Sadovsky Y, Nelson DM. Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol 2000; 278:C982-C988.
44. Crocker IP, Cooper S, Ong SC, Baker PN. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003; 162:637-643.
45. Aarts MM, Davidson D, Corluka A, Petroulakis E, Guo J, Bringhurst FR, Galipeau J, Henderson JE. Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis. J Biol Chem 2001; 276:37934-37943.
46. Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ, Stewart AF. Opposing mitogenic and antimitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci U S A 1997; 94:13630-13635.
47. Tovar Sepulveda VA, Shen X, Falzon M. Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. Endocrinology 2002; 143:596-606.
48. Lowes VL, Ip NY, Wong YH. Integration of signals from receptor tyrosine kinases and G protein-coupled receptors. Neurosignals 2002; 11:5-19.
49. Saito Y, Berk BC. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 2001; 33:3-7.
50. Abou-Samra AB, Juppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT Jr, Kronenberg HM, Segre GV. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A 1992; 89:2732-2736.
51. Crocker I, Kaur M, Hosking DJ, Baker PN. Rescue of trophoblast apoptosis by parathyroid hormone-related protein. BJOG 2002; 109: 218-220.
52. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995; 267: 2003-2006.
53. Liu Q, Schacher D, Hurth C, Freund GG, Dantzer R, Kelley KW. Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes. J Immunol 1997; 159:829-837.
54. Wu X, Fan Z, Masui H, Rosen N, Mendelsohn J. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 1995; 95:1897-1905.
55. Garcia-Lloret MI, Yui J, Winkler-Lowen B, Guilbert LJ. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol 1996; 167:324-332.
56. Alsat E, Haziza J, Scippo ML, Frankenne F, Evain-Brion D. Increase in epidermal growth factor receptor and its mRNA levels by parathyroid hormone (1-34) and parathyroid hormone-related protein (1-34) during differentiation of human trophoblast cells in culture. J Cell Biochem 1993; 53:32-42.
57. Gonzalez EA, Disthabanchong S, Kowalewski R, Martin KJ. Mechanisms of the regulation of EGF-receptor gene expression by calcitriol and parathyroid hormone in UMR 106-01 cells. Kidney Int 2002; 61: 1627-1634.
58. Roskams T, Desmet V. Parathyroid-hormone-related peptides. A new class of multifunctional proteins. Am J Pathol 1997; 150:779-785.
59. Ichizuka K, Morimoto T, Suzuki M, Sasaki Y, Kurihara H, Saito H, Yanaihara T. The effect of cytokines on parathyroid hormone-related protein (PTH-rP) production in human amnion cells. Endocr J 1999; 46:479-486.
60. Miyakoshi N, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 2001; 142:4349-4356.
61. Harvey AK, Yu XP, Frolik CA, Chandrasekhar S. Parathyroid hormone-(1-34) enhances aggrecan synthesis via an insulin-like growth factor-I pathway. J Biol Chem 1999; 274:23249-23255.
62. Druckmann R, Rohr UD. IGF-1 in gynecology and obstetrics: update 2002. Maturitas 2002; 41:S65-S83.
63. Halhali A, Bourges H, Carrillo A, Garabedian M. Lower circulating insulin-like growth factor I and 1,25-dihydroxyvitamin D levels in preeclampsia. Rev Invest Clin 1995; 47:259-266.
64. Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 1997; 176:751-758.
65. Halhali A, Tovar AR, Torres N, Bourges H, Garabedian M, Larrea F. Preeclampsia is associated with low circulating levels of insulin-like growth factor 1 and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 2000; 85:1828-1833.
66. Pang ZJ, Xing FQ. Expression of transforming growth factor β and insulin-like growth factor in molar and placental tissues. Arch Gynecol Obstet 2003; 269:1-4.
67. Shin JH, Ji C, Casinghino S, McCarthy TL, Centrella M. Parathyroid hormone-related protein enhances insulin-like growth factor-I expression by fetal rat dermal fibroblasts. J Biol Chem 1997; 272:23498-23502.
68. Green J, Goldberg R, Maor G. PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-1 axis. Kidney Int 2003; 63:487-500.
69. VanWijk MJ, Kublickiene K, Boer K, VanBavel E. Vascular function in preeclampsia. Cardiovasc Res 2000; 47:38-48.